Are these the 3 best growth stocks to own on the ASX?

Perpetual Limited (ASX:PPT), Sirtex Medical Limited (ASX:SRX) and Corporate Travel Management Ltd (ASX:CTD) performed exceptionally well in the first half and more is expected over the next few years.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors should always have several high-growth stocks in their portfolio to keep returns up. Dividend stocks bring in regular income, but the growth stocks can generate higher returns and extra funds that can be reinvested for further gains.

The three stocks below are some of the best performers in the ASX recently and they still have more room to run. Would they work well in your portfolios?

Corporate Travel Management Ltd (ASX: CTD) was recently added to the S&P/ASX 200 Index (ASX: XJO) (Index: ^AXJO) on the heels of a 47% increase in reported interim earnings per share. After listing in late 2010, the company which specialises in corporate travel solutions, has more than tripled revenue and quadrupled annual earnings per share.

It competes with Flight Centre Travel Group Ltd (ASX: FLT) for the business traveller and is holding its own. It has stable returns yet no long-term debt. It is forecast to double its earnings over the next two years. With a high-flying 42 price/earnings ratio, expected growth is baked into the price, so there's not a lot of margin of safety. Good company yet priced at a premium.

Perpetual Limited (ASX: PPT) had a remarkable result in financial year 2014 from its fund management business. First-half earnings were also up in the high-double digits. Interim dividends were raised 44% as well. In addition to its domestic share investments in the ASX, the fund manager is starting several funds that cover international equities to take advantage of stronger overseas markets and undervalued securities. The stock pays a 3.7% fully franked yield and is trading at 20 times forward earnings, close to its past PE average. Perpetual is priced well for the expected growth, so it would be a good addition to your portfolio.

Sirtex Medical Limited (ASX: SRX), the producer of a specialised liver cancer treatment, is growing well in the US healthcare market where it generates the majority of its revenue. Interim sales rose around 37%, marking its 42nd quarter of growth. High demand for its treatment continues and analysts forecast earnings to double from this financial year in the next two years. Growth in Europe and Asia is also expected. The stock trades at 34 times forward earnings. That may seem dear, but if earnings forecasts hold up, it could give a good return in the long term as it becomes another Aussie healthcare success story.

Motley Fool contributor Darryl Daté-Shappard does not own shares in any company mentioned.  We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policyThis article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »